Salarius Pharmaceuticals Inc (SLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,435 | 5,900 | 12,106 | 29,214 | 11,119 |
| Receivables | N/A | N/A | 1,611 | N/A | 3,856 |
| TOTAL | $2,988 | $6,520 | $14,520 | $30,164 | $15,797 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 23 |
| Intangibles | 0 | 0 | 0 | 8,866 | 8,866 |
| Other Non-Current Assets | 35 | 67 | 131 | 1,804 | 247 |
| TOTAL | $35 | $67 | $131 | $10,670 | $9,136 |
| Total Assets | $3,023 | $6,587 | $14,651 | $40,834 | $24,932 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 937 | 603 | 2,858 | 1,543 | 1,854 |
| Accrued Expenses | 352 | 407 | 1,408 | 568 | 383 |
| TOTAL | $1,511 | $1,299 | $4,266 | $2,111 | $2,237 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 477 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 59 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $536 |
| Total Liabilities | $1,511 | $1,299 | $4,266 | $2,111 | $2,773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116 | 36 | 21 | 16 | 15 |
| Common Shares | 0 | 0 | 0 | 0 | 2 |
| Retained earnings | -81,924 | -76,348 | -63,805 | -32,197 | -19,429 |
| TOTAL | $1,512 | $5,287 | $10,385 | $38,723 | $22,159 |
| Total Liabilities And Equity | $3,023 | $6,587 | $14,651 | $40,834 | $24,932 |